A recent case report published in Cancer Reports highlights the potential of epcoritamab as a viable treatment option for elderly patients with diffuse large B-cell lymphoma-type Richter syndrome (DLBCL-RS) that has proven refractory to conventional ... [5683 chars].. reed more
